Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 159KB)
Why become a member?

Exercise Elevates Blood Signature Difference Between People With, Without Chronic Fatigue Syndrome

Saturday 17 February 2018

 

From Stanford Medicine's Scope:

 

Treadmill
Calvin Klein
Model Lulu Tenney opens the Calvin Klein fall 2018 show
wearing a balaclava, an orange cropped safety jacket,
pants, and thigh-high white protective boots.
(Photo: Getty Images)
 

Exercise elevates blood signature difference between people with, without chronic fatigue syndrome

By Bruce Goldman
February 15, 2018
© Stanford Medicine 2018

A bout of exercise is about the last thing you'd imagine a person with chronic fatigue syndrome – also known as myalgic encephalomyelitis and often designated by the acronym ME/CFS – would want to endure. And you'd probably be right.

But a new study suggests that a blood test following exercise may be a very good way to differentiate between people who have ME/CFS and people who don't. That's important, because one of the things that have made efforts to treat and, perhaps, cure the debilitating disorder – which according to Stanford ME/CFS expert Jose Montoya, MD, afflicts between 1 million and 4 million people in the United States alone – almost preternaturally difficult has been the difficulty in establishing a definitive diagnosis for it. (That explains the large range in Montoya's estimate of the number of people with ME/CFS: A lot of people who have it don't know they have it – or at least their doctors don't.)

Recent work by Montoya and other Stanford researchers has identified a "signature" consisting of altered levels of as many as 17 different bloodborne substances in ME/CFS patients. But the signature is written in disappearing ink: Patients with an ME/CFS status of longer than three years in duration appear to lose it. Likewise, levels of some of these substances move in opposite directions among patients whose cases are more severe versus patients with less-severe cases.

 

Full article…

 


Arrow right

More Multiple Chemical Sensitivity news

 


 

blog comments powered by Disqus
Previous Previous Page